Expansion and cytotoxicity of mucosal CAR+ T cells in enterocolitis associated with BCMA CAR-T cell therapy
Ciltacabtagene autoleucel (cilta-cel) is a B cell maturation-antigen-targeting chimeric antigen receptor (CAR) T cell product approved for relapsed/refractory multiple myeloma treatment. Previously reported cases of post-cilta-cel immune effector cell enterocolitis (IEC-EC) have been described as a severe diarrhea associated with clonal CAR T cell populations. Here we report nine cases of cilta-cel-associated IEC-EC with CAR T cell-positive (CAR + ) infiltration in 158 cilta-cel-treated patients at MD Anderson Cancer Center (incidence of 5.1% at a 6-month landmark and 5.7% globally). Cilta-cel infiltration was the primary cause of IEC-EC, and all cases demonstrated monoclonal or oligoclonal T cell populations as measured by vector integration analysis, flow cytometry and T cell receptor sequencing. Patients with IEC-EC had 100-fold more CAR T cell persistence in the peripheral blood than patients without IEC-EC. RNA sequencing analysis revealed increased cytotoxic and inflammatory programs associated with the CAR + infiltrates relative to controls. Clonal vector integration occurred in introns of highly expressed genes without evidence of vector-mediated mutagenesis. Candidate driver mutations were sparse and heterogeneous, distinguishing IEC-EC from peripheral T cell lymphoma following CAR T cell therapy. In sum, we find that IEC-EC pathology represents a distinct, duodenum-predominant, clonal lymphoproliferative disorder characterized by the infiltration of clonal CAR + cytotoxic T cells into the gastrointestinal tract.
Authors
- Mahmoud Gaballa (ORCID: https://orcid.org/0000-0002-3928-6590)
- Francisco Vega (ORCID: https://orcid.org/0000-0001-5956-452X)
- Sharlene Dong (ORCID: https://orcid.org/0000-0002-6983-6012)
- Keyur Pravinchandra Patel (ORCID: https://orcid.org/0000-0001-5081-2427)
- Mark P. Hamilton (ORCID: https://orcid.org/0000-0002-3732-8910)
- Christopher D. Pacheco (ORCID: https://orcid.org/0009-0009-9921-5151)
- Surbhi Sidana (ORCID: https://orcid.org/0000-0003-3288-7614)
- Lekha Mikkilineni (ORCID: https://orcid.org/0009-0003-7698-5934)
- Paolo Strati (ORCID: https://orcid.org/0000-0002-7445-1459)
- Robert Zygmunt Orlowski (ORCID: https://orcid.org/0000-0002-5723-4129)
- Jared M. Henderson (ORCID: https://orcid.org/0000-0002-5121-5234)
- Sairah Ahmed (ORCID: https://orcid.org/0000-0001-7302-8299)
- David M. Richards (ORCID: https://orcid.org/0000-0002-4996-6063)
- M R Green (ORCID: https://orcid.org/0000-0001-6309-9472)
- Krina K. Patel (ORCID: https://orcid.org/0000-0002-8894-027X)
- Bita Sahaf (ORCID: https://orcid.org/0000-0002-4157-3863)
- Amy A. Ayers (ORCID: https://orcid.org/0000-0003-4807-2356)
- Sattva Swarup Neelapu (ORCID: https://orcid.org/0000-0003-1045-4914)
- Partow Kebriaei (ORCID: https://orcid.org/0000-0002-8607-9404)
- Oren Pasvolsky (ORCID: https://orcid.org/0000-0001-9193-0059)
- Wei‐Lien Wang (ORCID: https://orcid.org/0000-0001-8809-4424)
- David Bernard Miklos (ORCID: https://orcid.org/0000-0003-0717-4305)
- Christopher R. Flowers (ORCID: https://orcid.org/0000-0002-9524-3990)
- Snehit Prabhu (ORCID: https://orcid.org/0000-0001-8589-3087)
- Crystal Lee Mackall (ORCID: https://orcid.org/0000-0003-0359-9023)
- Sa A. Wang (ORCID: https://orcid.org/0000-0001-9385-9911)
- Aniruddha Mundhada (ORCID: https://orcid.org/0000-0001-6420-4932)
- Hector J Garcia Pleitez (ORCID: https://orcid.org/0009-0007-9711-7473)
- Francisco Cortina (ORCID: https://orcid.org/0009-0006-5239-7056)
- Ziyi Li (ORCID: https://orcid.org/0000-0001-8359-0533)
- Wei Wang (ORCID: https://orcid.org/0000-0001-6821-4556)
- Yinghong Wang (ORCID: https://orcid.org/0000-0002-5148-6130)
- Tania P. Sainz (ORCID: https://orcid.org/0009-0002-1476-5680)
- Karmila Murphy
- Xuehong Gui
- Carla Villela
- Swami P. Iyer
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Stanford Cancer Institute (US)
- Stanford University (US)
Publication Details
- Journal
- Nature Medicine
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41591-026-04731-w
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00